RxDoctor Payments Data

Barbara Blaue

Women's Health · Sullivan, MONPI 1417169855

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.9% of the total across 120 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 48.1% of the total. Reporting peaked in 2021 at $742 and has fallen 92.6% since, to $55 in 2025.

$2,378in general payments, 2019–2025

Across 120 payments — averaging $19.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$128
  • Astellas Pharma US Inc$123
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$109
  • Amgen$94
  • Dexcom, Inc.$88
  • plus $692 from 20 others

What the payments were for

  • Food & beverage$2,30597%
  • Education$733%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,378 in reported general payments places this provider in the 85th percentile of 208 women's health providers in Missouri.

See all women's health providers in Missouri

Medicare billing

Part B allowed, 2024
$1,187
Medicare patients
12
Services billed
20

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ibandronate Sodium47$504
Drospirenone-Ethinyl EstradiolEthinyl Estradiol/Drospirenone12$413
Estradiol (Once Weekly)Estradiol11$403
Vitamin D2Ergocalciferol (Vitamin D2)15$228
Levothyroxine Sodium23$154
Metformin Hcl ErMetformin Hcl14$39

Paid to pharmacies, not to this prescriber.

Other women's health in Sullivan

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →